Synthesis, molecular docking, ADMET, and evaluation of the anxiolytic effect in adult zebrafish of synthetic chalcone ( E )‐3‐(4‐(dimethylamino)phenyl)‐1‐(2‐hydroxyphenyl)prop‐2‐en‐1‐one: An in vivo and in silico approach
Fundamental & Clinical Pharmacology · 2024-04 · 38 (2) · 290-306
DOI: 10.1111/fcp.12960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, online erschienen am 16.10.2023. Verfasst von Larissa Santos Oliveira und 11 weiteren Autor:innen. Beteiligte Einrichtung: Science and Technology, Graduate Program in Natural Sciences, State University of Ceará, Fortaleza, Ceará, Brazil. Hauptthemen laut MEDLINE: Anti-Anxiety Agents, Chalcone, Chalcones. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Background
Anxiety disorders represent the complex interaction between biological, psychological, temperamental, and environmental factors; drugs available to treat anxiety such as benzodiazepines (BZDs) are associated with several unwanted side effects. Although there are useful treatments, there is still a need for more effective anxiolytics with better safety profiles than BZDs. Chalcones or 1,3‐diphenyl‐2‐proper‐1‐ones can be an alternative since this class of compounds has shown therapeutic potential mainly due to interactions with GABA A receptors and serotonergic system.
Objectives
This study evaluated the anxiolytic potential of chalcone ( E )‐3‐(4‐(dimethylamino)phenyl)‐1‐(2‐hydroxyphenyl)prop‐2‐en‐1‐one (C2OHPDA) in adult zebrafish ( Danio rerio ) (ZFa).
Methods
Each animal ( n = 6/group) was treated intraperitoneally (i.p.; 20 μL) with the chalcone (4, 20, and 40 mg/kg) and with the vehicle (DMSO 3%; 20 μL), being submitted to the tests of locomotor activity and 96‐h acute toxicity. The light/dark test was also performed, and the serotonergic mechanism (5‐HT) was evaluated through the antagonists of the 5‐HTR 1 , 5‐HTR 2A/2C , and 5‐HTR 3A/3B receptors. It was investigated the prediction of the chalcone's position and preferential orientation concerning its receptor, as well as the pharmacokinetic parameters (ADMET) involved in the process after administration.
Results
As a result, C2OHPDA was not toxic and reduced the locomotor activity of ZFa. Furthermore, chalcone demonstrated an anxiolytic effect on the central nervous system (CNS), mediated by the serotonergic system, with action on 5‐HT 2A and 5‐HTR 3A/3B receptors. The interaction of C2OHPDA with 5‐HT 2A R and 5‐HT 3A receptors was confirmed by molecular docking study, the affinity energy observed was −8.7 and −9.1 kcal/mol, respectively.
Conclusion
Thus, this study adds new evidence and highlights that chalcone can potentially be used to develop compounds with anxiolytic properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Science and Technology, Graduate Program in Natural Sciences, State University of Ceará, Fortaleza, Ceará, Brazil.
- Northeast Biotechnology Network, Graduate Program of Biotechnology, State University of Ceará, Fortaleza, Ceará, Brazil.
- Chemistry Course, State University of Vale do Acaraú, Sobral, Ceará, Brazil.
- Department of Organic and Inorganic Chemistry, Federal University of Ceará, Fortaleza, Ceará, Brazil.
ORCID-Profile: Márcia Machado Marinho, Hélcio Silva Dos Santos
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
Zitieren
APA
Santos Oliveira, L., Kueirislene Amâncio Ferreira, M., Wagner de Queiroz Almeida-Neto, F., Wlisses da Silva, A., Ivo Lima Pinto Filho, J., Nunes da Rocha, M., Machado Marinho, E., Henrique Ferreira Ribeiro, W., Machado Marinho, M., Silva Marinho, E., Eire Silva Alencar de Menezes, J., & Dos Santos, H. S. (2024). Synthesis, molecular docking, ADMET, and evaluation of the anxiolytic effect in adult zebrafish of synthetic chalcone ( E )‐3‐(4‐(dimethylamino)phenyl)‐1‐(2‐hydroxyphenyl)prop‐2‐en‐1‐one: An in vivo and in silico approach. Fundamental & Clinical Pharmacology, 38(2), 290-306. https://doi.org/10.1111/fcp.12960
Vancouver
Santos Oliveira L, Kueirislene Amâncio Ferreira M, Wagner de Queiroz Almeida-Neto F, Wlisses da Silva A, Ivo Lima Pinto Filho J, Nunes da Rocha M, et al. Synthesis, molecular docking, ADMET, and evaluation of the anxiolytic effect in adult zebrafish of synthetic chalcone ( E )‐3‐(4‐(dimethylamino)phenyl)‐1‐(2‐hydroxyphenyl)prop‐2‐en‐1‐one: An in vivo and in silico approach. Fundamental & Clinical Pharmacology. 2024;38(2):290-306. doi:10.1111/fcp.12960
BibTeX
@article{SantosOliveira2024,
author = {Santos Oliveira, Larissa and Kueirislene Amâncio Ferreira, Maria and Wagner de Queiroz Almeida-Neto, Francisco and Wlisses da Silva, Antonio and Ivo Lima Pinto Filho, José and Nunes da Rocha, Matheus and Machado Marinho, Emanuelle and Henrique Ferreira Ribeiro, Walber and Machado Marinho, Márcia and Silva Marinho, Emmanuel and Eire Silva Alencar de Menezes, Jane and Dos Santos, Hélcio Silva},
title = {Synthesis, molecular docking, ADMET, and evaluation of the anxiolytic effect in adult zebrafish of synthetic chalcone ( E )‐3‐(4‐(dimethylamino)phenyl)‐1‐(2‐hydroxyphenyl)prop‐2‐en‐1‐one: An in vivo and in silico approach},
journal = {Fundamental & Clinical Pharmacology},
year = {2024},
volume = {38},
number = {2},
pages = {290--306},
doi = {10.1111/fcp.12960}
}
EUVIMED